PROCEEDINGS PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP
|
|
- Gilbert Lucas
- 5 years ago
- Views:
Transcription
1 PRACTICAL APPLICATIONS: CASE STUDY REVIEWS* Bernard A. Cohen, MD, FAAP A HEALTHY 4-WEEK-OLD INFANT WITH ACNE A 4-week-old infant was brought to the pediatrician s office by his parents following the appearance of a widespread papular-pustular rash affecting his head and neck (Figure 1). The lesions first began to appear soon after birth. The infant was otherwise healthy, and a complete physical examination and review of systems were normal. Watchful waiting, with reassurance of the parents, was selected as an appropriate management strategy for this patient. The lesions resolved spontaneously over the course of the following 4 weeks. Many newborns exhibit rash that is characterized by varying combinations of neonatal acne, seborrheic dermatitis, milia, miliaria, tinea versicolor, or sebaceous hyperplasia. Neonatal acne commonly develops within 2 to 3 weeks of birth, and may include inflammatory lesions (ie, papules, pustules and, in some cases, cysts) and noninflammatory lesions (ie, open and closed comedones). Acne in newborns and infants occurs as a consequence of increased sebaceous gland activity during the first few months of life, which may be caused by elevated endogenous adrenal activity in girls, and by endogenous adrenal and testicular activity in boys. In 1 *Based on proceedings from a satellite symposium held during the American Academy of Pediatrics Annual Meeting on October 28, 2007, in San Francisco, California. Director of Pediatric Dermatology, Johns Hopkins Children s Center, Professor, Dermatology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland. Address correspondence to: Bernard A. Cohen, MD, FAAP, Professor, Dermatology and Pediatrics, Johns Hopkins University School of Medicine, East Baltimore Campus, 208 Brady Pediatric Dermatology, 600 North Wolfe Street, Baltimore, MD bcohen2@jhmi.edu. study, investigators performed clinical examinations and lesion counts in 22 infants (18 boys, 4 girls) with acne. 1 The mean age at the onset of lesions was approximately 3 weeks. Most of the patients exhibited papules and pustules, and some also exhibited open or closed comedones. Only 5 of the patients had comedonal acne only. A positive family history of severe acne was noted for only 3 of the patients. Skin biopsies were performed for 2 of the patients, revealing enlarged sebaceous follicles, sebaceous glands, and keratin plugging that were identical in appearance to the types of histological changes that are observed in preadolescent, adolescent, and adult acne. Six of the children were evaluated for the presence of Pityrosporum ovale, a fungal species that is associated with tinea versicolor, folliculitis (usually in immunocompromised individuals, but also occasionally in patients with intact immune function), and with a condition that has been referred to as benign cephalic pustulosis in the newborn (described in more detail later in this article). All of the P ovale smears were negative. On the basis of these findings, the investigators concluded that neonatal acne reflects transient sebaceous gland overactivity that is similar to that observed in older patients with acne, which probably occurs in response to endogenous androgens. These investigators also found that topical therapy helped to relieve acne symptoms for some patients. However, even without treatment, the acne had resolved in most patients within 1 to 3 months. Watchful waiting, with reassurance and education of the parents, are the principal treatments for neonatal acne. A low-risk topical preparation (eg, a topical antibiotic or topical benzoyl peroxide) is a reasonable option for some patients, especially if acne has persisted for more than 3 months. A short course of topical therapy may also help to reassure the parents. The most significant risk is skin irritation. Oral antibiotics may be prescribed for an otherwise healthy infant who is at high risk of scarring due to inflammatory acne. In Johns Hopkins Advanced Studies in Medicine 113
2 Figure 1.A Healthy 4-Week-Old Infant with Acne rare cases, neonatal acne may be caused by an inborn error of adrenal metabolism, and will be accompanied by other signs of hyperandrogenism. In a child with severe acne and normal growth parameters, assessment of bone age is a good screening study to exclude endocrinologic disorders. 2 During the past 10 to 15 years, several investigators have described a condition that has been referred to as neonatal cephalic pustulosis. It has been estimated that neonatal cephalic pustulosis may affect as many as 20% of newborns. 3 Neonatal cephalic pustulosis resembles acne in some respects, although differences in the clinical presentation between the 2 disorders have been noted. The lesions associated with neonatal cephalic pustulosis tend to be relatively uniform, with a widespread distribution that involves the cheeks, eyelids, and forehead. In some cases, the lesions may also extend to the scalp, neck, and the upper chest. As with neonatal acne, neonatal cephalic pustulosis tends to resolve after approximately 1 to 3 months, although it may persist for up to 12 months when there is involvement of the scalp. Several studies have linked neonatal cephalic pustulosis to skin colonization by the yeast genus Malassezia during the first few days after birth. In 1 study, the investigators cultured skin samples from 102 consecutive neonates with neonatal cephalic pustulosis. 4 At birth, 11 neonates and 36 mothers tested positive for Malassezia. At 3 weeks of age, 29 of 56 neonates (52%) and 18 of the mothers (32%) tested positive for Malassezia species. In addition, the investigators found a significant correlation between pustulosis and increased likelihood of Malassezia colonization among the affected infants. It has been hypothesized that these acneiform lesions may be caused by an inflammatory reaction that results from follicular occlusion by these lipophilic yeast species. 5 However, it is unclear whether infants with neonatal cephalic pustulosis represent a subset of patients with acne or whether this is actually a distinct condition. A HEALTHY ADOLESCENT MALE WITH SKIN OF COLOR This patient is a healthy 14-year-old black male with mixed comedonal and inflammatory acne (Figure 2). He had been using a nonprescription acne cleaner and scrub without improvement. He received a prescription for adapalene 0.1% cream, and was instructed to apply it every other night at bedtime. He was also given a benzoyl peroxide 5% wash to use before showering. The patient received instruction about skin care, including the use of nonirritating and noncomedogenic products. He was reminded not to expect clearing of his lesions within the first few days, and that treatment for several weeks would be required before his acne would improve sig- EVIDENCE-BASED PRACTICE RECOMMENDATION I. Practice Recommendation: Acne management guidelines developed by the American Academy of Dermatology recommend laboratory endocrinologic evaluation for children with acne who have signs of androgen excess (eg, body odor, axillary or pubic hair, and clitoromegaly). Determination of bone age using a hand film is a specific screening method for androgen excess that may be used before hormonal testing in prepubertal children. Name of AAFP-Approved Source: American Academy of Dermatology: Guidelines of Care for Acne Vulgaris Management. Specific Web Site of Supporting Evidence from Approved Source: _docs/clinicalresearch_acne%20vulgaris.pdf. Strength of Evidence: An expert consensus panel convened by the American Academy of Dermatology noted that there is little evidence to support routine endocrinologic evaluation for patients with acne, as most patients exhibit hormone concentrations within the normal range. The panel recommended hormonal testing for patients with other signs of hyperandrogenism. Determination of bone age was identified as an effective screening tool for selecting candidates for hormonal testing in prepubertal children. 114 Vol. 8, No. 4 March 2008
3 PROCEEDINGS Figure 2. Acne in a Healthy 14-Year-Old Boy with Darkly Pigmented Skin nificantly. At a follow-up examination 4 weeks later, his acne had begun to improve and he had not experienced significant skin irritation. His adapalene treatment was increased to once daily at bedtime. Patients of color who have acne are at substantial risk of postinflammatory hyperpigmentation and keloidal scarring.6,7 In many cases, it is the hyperpigmentation, and not the acne, that is the patient s primary complaint. Early and aggressive management is especially important in patients with darkly pigmented skin to prevent postinflammatory hyperpigmentation and scarring. Several studies have demonstrated that topical retinoids improve acne symptoms and hyperpigmentation in patients of color. The effects of tazarotene cream for the treatment of postinflammatory hyperpigmentation were examined in a double-blind, vehicle-controlled study of patients of color with acne.8 A total of 74 patients with darker skin (Fitzpatrick skin types III VI), mild-to-moderate acne, and postinflammatory hyperpigmentation were randomized to receive tazarotene 0.1% cream or vehicle for up to 18 weeks. Tazarotene treat- Johns Hopkins Advanced Studies in Medicine ment significantly improved overall disease activity, area of hyperpigmentation, and intensity of hyperpigmentation. On a pigmentation intensity scale of 0 (no hyperpigmentation) to 5 (severe, prominent, and dense hyperpigmentation), tazarotene was associated with a mean improvement of 1.1 grades from baseline versus 0.5 grades with vehicle (P =.04). The results obtained from a representative patient at baseline and after 6 and 18 weeks of treatment are shown in Figure 3, demonstrating marked improvement with tazarotene. In a second study, Taylor et al examined the efficacy of a topical retinoid, in combination with topical benzoyl peroxide and clindamycin, in a racially diverse group of patients from a community setting.9 All patients were treated with a topical gel of clindamycin 1% and benzoyl peroxide 5%, and were randomized to additional therapy with 1 of 3 different topical retinoids tretinoin microsphere 0.04%, tretinoin microsphere 0.1%, or adapalene gel 0.1%. Patients in all 3 treatment groups exhibited significant decreases from baseline in acne severity, including counts of both noninflammatory and inflammatory lesions. In patients of color, all 3 retinoids also improved postinflammatory hyperpigmentation. The effectiveness of retinoid treatment must be balanced against the risk of skin irritation, as severe irritation may exacerbate hyperpigmentation. The risk of irritation is reduced by instructing the patient to apply the topical retinoid 2 to 3 days a week for the Figure 3. Effects of Tazarotene on Acne and Hyperpigmentation in a Patient with Darkly Pigmented Skin From left to right, the images show acne lesions and hyperpigmentation at baseline and after 6 weeks and 18 weeks of treatment. Reprinted with permission from Grimes and Callender. Cutis. 2006;77:
4 Figure 4. A Healthy 10-Year-Old Girl with an Asymptomatic Eruption for 3 Months, Unresponsive to Nonprescription Hydrocortisone first few weeks, increasing to daily treatment after the patient s skin has adapted to the retinoid. A 10-YEAR-OLD GIRL WITH PERIORIFICIAL DERMATITIS A healthy 10-year-old girl was referred to a dermatologist for evaluation of an asymptomatic facial eruption that had developed 3 months previously (Figure 4). Her primary care physician had attempted to treat the eruption using an over-the-counter hydrocortisone product, without noticeable improvement. She was diagnosed with periorificial dermatitis, with a typical clinical presentation that included the presence of uniform red papules without comedones or lichenificiation around the mouth, sparing of the vermillion, and involvement of the cheek within the nasolabial folds. She was treated with oral erythromycin 200 mg per day. She did not improve after 1 month of oral erythromycin, but the lesions resolved after a second month of treatment, and the antibiotic was discontinued. She exhibited a brief, mild exacerbation of dermatitis following the discontinuation of antibiotic therapy. Periorificial dermatitis is a childhood variant of rosacea that typically presents as an acneiform eruption around the mouth, nose, or eyes, and that is often accompanied by pruritus or burning. 10 Few studies have examined the characteristics of periorificial dermatitis in pediatric patients. Nguyen and Eichenfield performed a retrospective chart review, with telephone follow-up, of 79 patients with periorificial dermatitis between the ages of 6 months and 18 years. 10 The average time between symptom onset and diagnosis was 8 months. Perioral lesions were noted for 70% of the patients, periocular lesions for 25%, perinasal lesions for 43%, and perivulvar lesions for 1%. Most of the patients (72%) had previously been treated with topical or intranasal steroids. Topical metronidazole cream was effective for many patients, with resolution of symptoms occurring after an average of 7 weeks. Although intranasal, topical, or oral steroids have been implicated in many patients, most of our patients denied a history of exposure to topical or systemic steroids. A biopsy is not necessary for the diagnosis of this condition. Topical metronidazole and other topical antibiotics may improve symptoms. However, patients with perioral dermatitis often exhibit significant skin irritation and may be unable to tolerate topical therapy. Oral erythromycin is an effective EVIDENCE-BASED PRACTICE RECOMMENDATION II. Practice Recommendation: Acne in patients of color is associated with a high risk of scarring and postinflammatory hyperpigmentation. Topical retinoids are effective for the treatment of acne and postinflammatory hyperpigmentation in these patients. Name of AAFP-Approved Source: Jacyk WK. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol. 2001;15(suppl 3): Specific Web Site of Supporting Evidence from Approved Source: entrez?db=pubmed&cmd=showdetailview&termto Search= &ordinalpos=10&itool=Entrez System2.PEntrez.Pubmed.Pubmed_ResultsPanel. Pubmed_RVDocSum. Strength of Evidence: Individuals with darkly pigmented skin are at high risk of acne scarring and hyperpigmentation, yet few clinical studies have specifically assessed acne treatment in these patients. A recent study examined the effects of topical adapalene 0.1% gel in 65 black South African patients with acne. Topical retinoid treatment reduced the number of hyperpigmented macules and the density of hyperpigmentation in approximately 66% of the patients. 116 Vol. 8, No. 4 March 2008
5 alternative for prepubertal children, who are less likely to develop gastritis than older patients. REFERENCES 1. Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol. 1999;38: Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56: Cantatore-Francis JL, Glick SA. Childhood acne: evaluation and management. Dermatol Ther. 2006;19: Bernier V, Weill FX, Hirigoyen V, et al. Skin colonization by Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol. 2002;138: Bergman JN, Eichenfield LF. Neonatal acne and cephalic pustulosis: is Malassezia the whole story? Arch Dermatol. 2002;138: Callender VD. Considerations for treating acne in ethnic skin. Cutis. 2005;76: Taylor SC. Cosmetic problems in skin of color. Skin Pharmacol Appl Skin Physiol. 1999;12: Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77: Taylor SC. Maximizing combination therapy in ethnic skin. Paper presented at 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, Hawaii. 10. Nguyen V, Eichenfield LF. Periorificial dermatitis in children and adolescents. J Am Acad Dermatol. 2006;55: Johns Hopkins Advanced Studies in Medicine 117
ACNE. What are the aims of this leaflet?
ACNE What are the aims of this leaflet? This leaflet has been written to help you understand more about acne - what it is, what causes it, what can be done about it and where you can find out more about
More informationACNE UPDATE 2017 FACULTY DISCLOSURE ACNE UPDATE
ACNE UPDATE 2017 PATRICIA TREADWELL, M.D. PROFESSOR OF PEDIATRICS AND DERMATOLOGY IU SCHOOL OF MEDICINE FACULTY DISCLOSURE I have no relevant financial relationships with the manufacturer(s) of any commercial
More informationAcne Workshop Pediatric Acne: What s Erupting? AZAAP. Marcia Hogeling, MD, FAAD, FAAP
Acne Workshop Pediatric Acne: What s Erupting? AZAAP Marcia Hogeling, MD, FAAD, FAAP Disclosures Advisory Board Leo Pharma & Anacor Off label use of acne medicines Objectives Diagnose comedonal, inflammatory
More informationACNE BOOT CAMP TOPICAL THERAPY BASICS
ACNE BOOT CAMP TOPICAL THERAPY BASICS Lawrence J Green, MD Associate Clinical Professor of Dermatology George Washington University School of Medicine Washington DC Relevant Disclosures Investigator -Allergan,
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 January 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 January 2012 EPIDUO, gel Tube of 30 g (CIP code: 383 814-6) Tube of 60 g (CIP code: 383 816-9) Applicant: GALDERMA
More informationX-Plain Acne Reference Summary
X-Plain Acne Reference Summary Nearly 17 million people in the United States have acne, making it one of the most common skin diseases in the USA. Although acne is not a serious health threat, severe acne
More informationWorld Journal of Pharmaceutical Research
Shraddhamayananda SJIF Impact Factor 5.045 Volume 3, Issue 6, 618-625. Research Article ISSN 2277 7105 EFFICACY OF HOMEOPATHIC MEDICINES IN THE TREATMENT OF ACNE *Swami Shraddhamayananda Ramakrishna Mission
More informationAcne vulgaris is a disease of the pilosebaceous unit (i.e., the sebaceous glands and adjacent hair follicle).
Dr. Ghassan Salah Acne is a common, chronic inflammatory disorder of the pilosebaceous unit in which a microcomedo develops as the initial condition. The most common form of acne is acne vulgaris. Other
More informationACNE. Jason M Cheyney, MPAS, PA-C Dermatologic Surgery Specialists Macon, Ga 31211
ACNE Jason M Cheyney, MPAS, PA-C Dermatologic Surgery Specialists Macon, Ga 31211 Pathogenesis of Acne Causative Factors Therapy On the horizon Approximately 45 million Americans have acne It is often
More informationTopical Retinoids Prior Authorization Criteria Program Summary
Topical Retinoids Prior Authorization Criteria Program Summary OBJECTIVE The intent of the Retinoids Prior Authorization (PA) criteria is to discourage use of the listed target agents for the treatment
More informationAcne Vulgaris. This non promotional presentation has been sponsored and developed by Galderma for UK healthcare professionals only.
Acne Vulgaris [Speaker Name] [Speaker Title] This non promotional presentation has been sponsored and developed by OTH18-07-0203 DOP: August 2018 Learning Objectives Explain the pathophysiology of acne
More informationInternational Journal of Pharma and Bio Sciences
Research Article Pharmacology International Journal of Pharma and Bio Sciences ISSN 0975-6299 COMPARISION OF CLINICAL EFFICACY OF TOPICAL CLINDAMYCIN WITH ADAPALENE AND ADAPALENE ALONE IN TREATMENT OF
More informationACNE VULGARIS: DIAGNOSIS AND TREATMENT
ACNE VULGARIS: DIAGNOSIS AND TREATMENT Federal Bureau of Prisons Clinical Guidance DECEMBER 2017 Clinical guidance is made available to the public for informational purposes only. The Federal Bureau of
More informationDermclinic
Dermclinic /Dermclinic A Photo Quiz to Hone Dermatologic Skills DAVID L. KAPLAN, MD Series Editor University of Missouri Kansas City, University of Kansas Case 1: Upon his return from a summer visit to
More informationالاكزيماتيد= Eczematid
1 / 7 2 / 7 Pityriasis Debate confusing of hypopigmentation characterized increasing surrounded differ hypomelanotic "progressive exists alba misnomer extensive a to observed term the applied term derived
More informationRashes Not To Be Missed In Children
May 2016 Rashes Not To Be Missed In Children Dr Chan Yuin Chew Dermatologist Dermatology Associates Gleneagles Medical Centre Scope of presentation Focus on rashes May lead to significant morbidity if
More informationAcne. S Afr Fam Pract REVIEW. Abstract. Introduction. Pathogenesis. Lynn Lambert a* Amayeza Info Centre *
South African Family Practice 2015; 57(6):16-20 Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0] http://creativecommons.org/licenses/by-nc-nd/4.0 S Afr
More informationObjectives. 1. Recognizing benign skin lesions. 2.Know which patients will likely need surgical intervention.
The Joy of Pediatric Skin Dr. Claire Sanger University of Kentucky Plastic & Reconstructive Surgery Objectives 1. Recognizing benign skin lesions 2.Know which patients will likely need surgical intervention.
More informationThe skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis
Dermatology The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis The image to the left shows an image of skin cells and the proteins which
More informationAn Efficacy Study of 3 Commercially Available Hydroquinone 4% Treatments for Melasma
An Efficacy Study of 3 Commercially Available Hydroquinone 4% Treatments for Melasma Pearl E. Grimes, MD Melasma is a common disorder of hyperpigmentation typically characterized by relatively symmetric
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abnormal wound healing Acne and cybereducation, 131 and Google, 129 131 and online dangers, 131, 132 reliable online resources on, 130 self-proclaimed
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationManagement of Truncal Acne Vulgaris: Current Perspectives on Treatment
DRUG THERAPY TOPICS Management of Truncal Acne Vulgaris: Current Perspectives on Treatment James Q. Del Rosso, DO Acne vulgaris is one of the most common disorders encountered by dermatologists in the
More informationDuring the last 20 years, the number of topical
THERAPEUTICS FOR THE CLINICIAN Cumulative Irritation Potential of Adapalene 0.1% Cream and Gel Compared With Tretinoin Microsphere 0.04% and 0.1% Jonathan S. Dosik, MD; Kenneth Homer, MS; Stéphanie Arsonnaud
More informationF r e q u e n t l y A s k e d Q u e s t i o n s
Acne who specializes in treating skin problems) about how you can help prevent acne and if treatment would help you. Q: What is acne? A: Acne is a disorder that causes outbreaks of skin lesions commonly
More informationOral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study
Original Article Oral Azithromycin Pulse Therapy and Daily Topical Adapalene in the Treatment of Acne Vulgaris: An Open Randomized Noncomparative Study Chowdhury MAH 1, Mamun SA 2, Uddin MJ 3, Khan RM
More informationA Novel Approach for Acne Treatment
A Novel Approach for Acne Treatment E.V. Ross, M.D.; M.A. Blair, M.D.; B.S. Graham, M.D.; Naval Medical Center, San Diego, CA D.Y. Paithankar, Ph.D.; B.A. Saleh, M.Eng.; Candela Corporation, Wayland, MA
More informationPrescribing Information
Prescribing Information Pr DERMOVATE Cream (clobetasol propionate cream, USP) Pr DERMOVATE Ointment (clobetasol propionate ointment, USP) Topical corticosteroid TaroPharma Preparation Date: A Division
More informationEvidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada. Catherine Zip Nov 10, 2016
Evidence-based Clinical Practice Guidelines for Treatment of Acne and Rosacea in Canada Catherine Zip Nov 10, 2016 Acne Acne Classification Type Comedonal Mild-to-moderate papulopustular acne Severe Description
More informationACNE THERAPY Experience with Palomar LuxV Intense Pulsed Light Therapy
ACNE THERAPY Experience with Palomar LuxV Intense Pulsed Light Therapy Robert S. Berger, MD, FAAD, FASDS., Assistant Professor, Department of Dermatology, The Johns Hopkins University, Baltimore, Private
More informationOral Azithromycin Pulse Therapy and Daily Topical Benzoyl Peroxide in the Treatment of Acne Vulgaris: An Open Clinical Trial Study
Journal of Bangladesh College of Physicians and Surgeons Vol. 36, No. 1, January 218 Oral Azithromycin Pulse Therapy and Daily Topical Benzoyl Peroxide in the Treatment of Acne Vulgaris: An Open Clinical
More informationReview Acne Pathogenesis Clinical Evaluation Treatment Guidelines
Tiffany Herd, MD Pediatric Dermatology Fellow Baylor College of Medicine/Texas Children's Hospital Review Acne Pathogenesis Clinical Evaluation Treatment Guidelines Psychosocial Impact of Acne Acne is
More informationTime to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service
Time to Learn 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service The Red Face Rosacea Acne Seborrhoeic eczema eczema Psoriasis Slapped cheek syndrome Fungal infection Erysipelas...
More informationCommon Dermatological Conditions in Adults in Ghana. Margaret Lartey FWACP
Common Dermatological Conditions in Adults in Ghana Margaret Lartey FWACP Outline Introduction Two Common disorders Discussion Case 1 34 yr old female C/o pruritus of 2 months duration First episode Seen
More informationMEDICAL SKINCARE ASSESSMENT
MEDICAL SKINCARE ASSESSMENT Patient Name Date Address (City) (State) (Zip) Phone (Home) (Cell) (Work) Date of Birth Who Referred You? Email Address: Emergency Contact Phone PERSONAL HISTORY Do you wear
More informationPatients who suffer from mild-to-moderate acne are
[ORIGINAL RESEARCH] Self-diagnosis of Mild-to-Moderate Acne for Self Treatment with Blue Light Therapy a MICHAEL H. GOLD, MD; b ANNEKE ANDRIESSEN; a JULIE BIRON a Tennessee Clinical Research Center, Nashville,
More informationAzithromycin Therapy for Multiple Eruptive Milia: A Report of a Case, New Treatment Option, and Review of the Literature
ISPUB.COM The Internet Journal of Dermatology Volume 7 Number 1 Azithromycin Therapy for Multiple Eruptive Milia: A Report of a Case, New Treatment Option, and Review of the Literature E McCarley O'Shea,
More informationAcne is one of the most common skin diseases. It usually occurs during adolescence, but can
DOI: 10.5124/jkma.2010.53.7.623 pissn: 1975-8456 eissn: 2093-5951 http://jkma.org Pharmacotherapeutics Pharmacologic Treatment of Acne Dae Hun Suh, MD Department of Dermatology, Seoul National University
More informationInt. J. Pharm. Sci. Rev. Res., 29(1), November December 2014; Article No. 34, Pages:
Research Article A Comparative Study to Evaluate the Efficacy and Safety of Topical Isotretinoin and Versus Adapalene and in The Treatment of Grade I II Acne Vulgaris of Face Dr. Jyotirmoy Adhikary* 1,
More informationNote for John Doe on 02/08/ Chart 17492
Note for John Doe on 02/08/2005 - Chart 17492 Chief Complaint (1/1): This 35-year-old male presents today for evaluation of acne. Acne HPI: Patient indicates acne is located on the dorsum of nose and manifest
More informationManagement of Acne in Primary Health Care: The good, the bad and the ugly
Management of Acne in Primary Health Care: The good, the bad and the ugly Marie-Lyne Bournival BSc, PG Dip (Health Sc), MN Nurse Practitioner Hei Hei Health Centre Christchurch, New Zealand Wednesday 29
More informationFacial Rash. Facial Rash 10/14/2013. Ten Look Alike Rashes Michelle DiBaise, MPAS, PA-C, DFAAPA Associate Clinical Professor NAU PA Program
Ten Look Alike Rashes Michelle DiBaise, MPAS, PA-C, DFAAPA Associate Clinical Professor NAU PA Program Facial Rash Facial Rash Case 1 28 year female Progressive development of erythematous facial lesions
More informationSix-Month Safety Results of Calcium Hydroxylapatite for Treatment of Nasolabial Folds in Fitzpatrick Skin Types IV to VI
Six-Month Safety Results of Calcium Hydroxylapatite for Treatment of Nasolabial Folds in Fitzpatrick Skin Types IV to VI ELLEN S. MARMUR, MD, SUSAN C. TAYLOR, MD, y PEARL E. GRIMES, MD, z CHARLES M. BOYD,
More informationPHARMACY PRACTICE I PHCY280 (2 CREDITS); PHCY280L (1CREDIT) SUMMER Christy Mary Sam
PHARMACY PRACTICE I PHCY280 (2 CREDITS); PHCY280L (1CREDIT) SUMMER 2014-15 1 Christy Mary Sam COMMUNICATION SKILLS Communication is the process involved with the exchange of any kind of information between
More information50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate).
DUPISOR Composition Gel 50 microgram/g Calcipotriol and 500 microgram/g betamethasone (as dipropionate). Action Calcipotriol is a non-steroidal antipsoriatic agent, derived from vitamin D. Calcipotriol
More informationWhat causes pimples in the first place? Dr. Melissa K. Levin, a board-certified dermatologist, breaks it down for us:
Ah, acne something that s plagued many of us during our teenage years, or may still be plaguing us currently as adults. Whether we re blessed to deal with a nose full of blackheads or more serious, painful,
More informationKLERESCA ACNE TREATMENT NO MORE HIDING. Using fluorescent light energy to treat your acne
KLERESCA ACNE TREATMENT NO MORE HIDING Using fluorescent light energy to treat your acne Introducing a new technology that boosts your own healing mechanisms 1-8 Non-invasive treatment Using fluorescent
More informationUpdate of Rosacea. Case 1. Case 2 8/15/2017
Update of Rosacea Dr Samantha Eisman Dermatologist Sinclair Dermatology MBChB MRCP(UK) FCDerm(SA) FACD Case 1 Your 55 year old cousin calls and asks advise about her red face. What is your differential
More informationStaying A- Head in Pediatric Dermatology:
Staying A- Head in Pediatric Dermatology: Common Scalp and Hair Diagnoses Matt Grisham, MD Greenville Health System Post-Graduate Seminar April 20, 2016 I have no financial disclosures or conflicts of
More informationNEHSNORTH EASTERN HEALTH SPECIALISTS
COSMETIC DERMATOLOGY NEHSNORTH EASTERN HEALTH SPECIALISTS nehs.com.au CONSENT FORM VASCULAR Treatment with BBL & LASERS I, DOB:, of authorize of North Eastern Health Specialist to perform hair removal
More informationEvidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne
SUPPLEMENT ARTICLE Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne AUTHORS: Lawrence F. Eichenfield, MD, a Andrew C. Krakowski, MD, a Caroline Piggott, MD, a James Del
More informationRegulatory Status FDA approved indication: Tretinoin products are indicated for the topical treatment of acne vulgaris (5-16).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.03 Subject: Tretinoin Page: 1 of 5 Last Review Date: September 15, 2017 Tretinoin Description Atralin
More informationPrescribing Information. Taro-Clobetasol. Taro-Clobetasol
Prescribing Information Pr Taro-Clobetasol Clobetasol Propionate Cream USP, 0.05% w/w Pr Taro-Clobetasol Clobetasol Propionate Ointment USP, 0.05% w/w Therapeutic Classification Topical corticosteroid
More information30-Aug-17 ACNE IN THE POST ADOLESCENT FEMALE DR J VON NIDA ROYAL STREET DERMATOLOGY SIR CHARLES GAIRDNER HOSPITAL DISCLAIMER ACNE
DISCLAIMER ACNE IN THE POST ADOLESCENT FEMALE DR J VON NIDA ROYAL STREET DERMATOLOGY SIR CHARLES GAIRDNER HOSPITAL No conflicts of interest ACNE Multifactorial Disorder of the Pilosebaceous Unit Clinically
More information7/13/09. Definition. Infections Due to Malassezia. Case Report 1. Case Report 1 (cont.) Case Report 1 (cont.)
Definition Infections Due to Malassezia Various species of Malassezia cause both opportunistic, superficial infections and occasionally systemic infections Common superficial infections include: Pityriasis
More informationHIDRADENITIS SUPPURATIVA
Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Copyright 2004-2005 The McGraw-Hill Companies. All rights reserved. Fitzpatrick Color Atlas, 5e
More informationInteresting Cases in Dermatology: Clinical Pearls for Primary Care Providers
Interesting Cases in Dermatology: Clinical Pearls for Primary Care Providers 26 th Annual Southwestern Conference on Medicine Tucson, Arizona Friday, April 28 th, 2017 Shannon C. Trotter DO, FAOCD, FAAD
More informationADULT FEMALE ACNE IS NOT TEENAGE ACNE
ABSTRACT BOOK Satellite Symposium EADV 2011 ADULT FEMALE ACNE IS NOT TEENAGE ACNE Chair: Professor Dr. Brigitte Dréno October 22 nd Room: Auditorium III F_Abstract Book Skinoren.indd 1 07/09/11 18:24 Program
More informationTable of Contents: Part 1 Medical Dermatology. Chapter 1 Acneiform Disorders. Acne. Acne Vulgaris. Pomade Acne. Steroid Acne
Table of Contents: Part 1 Medical Dermatology Chapter 1 Acneiform Disorders Acne Acne Vulgaris Pomade Acne Steroid Acne Infantile Acne Pediatric Perspectives Neonatal Acne (Acne Neonatorum) Pediatric Perspectives
More informationTypes of Skin Infections
Anatomy of Skin Types of Skin Infections Bacterial Impetigo Folliculitis Acne Fungal /Parasitic Tinea Pedis Tinea Cruris Tinea Versicolor Tinea Corporis Toenail fungus Allergic/Irritation conditions Dermatitis
More informationTreatment of adult female acne: a new challenge
DOI: 10.1111/jdv.13188 JEADV REVIEW ARTICLE Treatment of adult female acne: a new challenge B. Dreno* Department of Dermato-Cancerology, University of Nantes, Nantes, France *Correspondence: B. Dreno.
More informationDermatology for the PCP
Dermatology for the PCP Laura S. Winterfield, MD MPH Associate Professor Medical University of South Carolina I have no relevant conflicts of interest. 1 Learning Objectives Identify common skin conditions
More informationDOI /j x
THERAPEUTICS DOI 1.1111/j.1365-2133.27.883.x Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris A. Charakida,
More informationAndrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada
Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada Copyright 2017 by Sea Courses Inc. All rights reserved.
More informationICHTHYOSIS. What are the aims of this leaflet?
ICHTHYOSIS What are the aims of this leaflet? This leaflet has been written to help you understand more about ichthyosis. It will tell you what it is, the types of ichthyosis, what can be done about it,
More informationREGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth
REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES R e g i S C A R PATIENT'S DATA Initials of the patient date of birth Age country of birth Gender male female
More informationChapter 8 Skin Disorders and Diseases
Chapter 8 Skin Disorders and Diseases Attitude is more important than the past, than education, than money, than circumstances, than what people do or say. It is more important than appearance, giftedness,
More informationLUMACIP PLUS Cream (Fluocinolone acetonide 0.01% + Hydroquinone 4% + Tretinoin 0.05%)
Published on: 10 Jul 2014 LUMACIP PLUS Cream (Fluocinolone acetonide 0.01% + Hydroquinone 4% + Tretinoin 0.05%) Composition LUMACIP PLUS Cream Each gram contains: Fluocinolone acetonide IP.. 0.01% w/w
More informationCutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university
Cutanous Manifestation of Lupus Erythematosus Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university A 50-year old lady, who is otherwise healthy, presented to the dermatology clinic with
More informationAcne is the most common PSU disorder which develops when the pores of the PSU get blocked.
Published on: 7 Nov 2010 Acne: Overview Introduction Acne, more commonly called as pimples: is the most common skin disorder seen in adolescence. Spontaneous regression usually occurs after 20 years of
More informationEFFECT OF ORCHIECTOMY AND OOPIIORECTOMY UPON EXISTENT AND POTENTIAL ACNE*
EFFECT OF ORCHIECTOMY AND OOPIIORECTOMY UPON EXISTENT AND POTENTIAL ACNE* JAMES B. HAMILTON, PH.D. AND GORDON E. MESTLER That androgens are the prime incitants of acne in males and virilized females finds
More informationAcne Related Procedures ACNE RELATED PROCEDURES HS-258. Policy Number: HS-258. Original Effective Date: 9/4/2014. Revised Date(s): 6/8/2015
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationSubspecialty Rotation: Dermatology
Subspecialty Rotation: Dermatology Faculty: Wesley Galen, M.D. GOAL: Prevention, Counseling and Screening (Dermatology). Understand the pediatrician's role in preventing illness and dysfunction related
More informationEducation. Acne (acne vulgaris) is a. Putting out the spot fires. ClinicalReview AUTHOR. Learning objectives
ClinicalReview Learning objectives Understand the physiological determinants of acne development Understand the topical and systemic treatment of acne Understand the non-pharmacological treatment of acne
More informationDouglas N. Robins, M.D. Ameriderm Research
Curriculum Vitae Douglas N. Robins, M.D. Ameriderm Research Office Address: Leavitt Medical Associates of Florida (DBA) Advanced Dermatology and Cosmetic Surgery Ameriderm Research 4100 Southpoint Dr.
More informationNew Formulations and Research Support Individualized, Adherence-Promoting Topical Acne Regimens
New Formulations and Research Support Individualized, Adherence-Promoting Topical Acne Regimens Good tolerability, convenience, and simplicity all positively influence adherence with topical acne therapy.
More informationUpdates in the Management of Epidermal Growth Factor Receptor (EGFR) Inhibitors- Induced Skin Rash. Outline. Signal Transduction
Updates in the Management of Epidermal Growth Factor Receptor (EGFR) Inhibitors- Induced Skin Rash Siu-Fun Wong, PharmD, FASHP, FCSHP Associate Professor of Pharmacy Practice Western University of Health
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 25 Jul 2018 13:50:16 GMT) CTRI Number Last Modified On 10/05/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationAcne. Questions Answers & about...
Questions Answers & about... Acne National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) National Institutes of Health Public Health Service U.S. Department of Health and Human Services
More informationComparative Study of Efficacy And Safety of Clindamycin 1% Gel And Nadifloxacin 1% Cream In Patients With Mild To Moderate Acne Vulgaris
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 12 Ver. XIV (Dec. 2017), PP 12-22 www.iosrjournals.org Comparative Study of Efficacy And Safety
More informationQuestions 1. What is the diagnosis? 2. What is the significance? 3. What is the treatment? Provided by: Dr. Alexander K.C. Leung
Illustrated quizzes on problems seen in everyday practice Case 1 Rash on the Neck Copyright An eight-year-old girl presents with an erythematous rash on the neck. The rash is slightly itchy. Incidentally,
More informationThursday, 21 October :53 - Last Updated Thursday, 11 November :27
1 / 15 2 / 15 3 / 15 4 / 15 Pityriasis Alba Background Pityriasis alba is a nonspecific dermatitis of unknown etiology that causes erythematous scaly patches. These resolve and leave areas of hypopigmentation
More informationKEY ISSUES IN SKIN OF COLOR
KEY ISSUES IN SKIN OF COLOR Amy McMichael, MD Professor and Chair Department of Dermatology Wake Forest Baptist Medical Center Winston-Salem, NC Real World for Residents 2017 SC Derm 2019 1 DISCLOSURE/CONFLICTS
More informationConflicts. Objectives. University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 24 August Pediatric Dermatology 101
Pediatric Dermatology 101 John C. Browning, MD, FAAD, FAAP Conflicts Investigator: ViroXis Advisor: ViroXis Advisory Board: TopMD Speaker: Galderma Objectives Understand the meaning and importance of cutaneous
More informationDermatology for the Internist DREW M ANDERSON, MD VOLUNTEER CLINICAL ASSISTANT PROFESSOR OF MEDICINE, INDIANA UNIVERSITY SCHOOL OF MEDICINE
Dermatology for the Internist DREW M ANDERSON, MD VOLUNTEER CLINICAL ASSISTANT PROFESSOR OF MEDICINE, INDIANA UNIVERSITY SCHOOL OF MEDICINE Why Should I Care? 53% of all skin related visits are to non
More informationOBSERVATIONS ON THE EFFECT OF CORTISONE IN ACNE VULGARIS*
OBSERVATIONS ON THE EFFECT OF CORTISONE IN ACNE VULGARIS* J. W. DIDCOCT, M.D. It is generally accepted that androgenic hormones play an important role in the pathogenesis of acne vulgaris. Various studies
More informationRosacea. This non promotional presentation has been sponsored and developed by Galderma for UK healthcare professionals only.
Rosacea [Speaker Name] [Title] This non promotional presentation has been sponsored and developed by OTH18-07-0214 DOP: September 2018 Learning Objectives To review current guidelines for best practice
More informationAcne vulgaris is one of the most common conditions
[LITERATURE REVIEW] A Review of Acne in Ethnic Skin Pathogenesis, Clinical Manifestations, and Management Strategies a ERICA C. DAVIS, MD; a,b VALERIE D. CALLENDER, MD a Callender Skin & Laser Center,
More informationPanel: Practice Pearls from the Pros. Prescription Medication: Office Protocols. Kathy Jones, BSN, RN, CPSN
24TH Annual Meeting Panel: Practice Pearls from the Pros Prescription Medication: Office Protocols Kathy Jones, BSN, RN, CPSN Upon completion of this presentation, the participants will self-report an
More informationClinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE
Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE Includes guidance for the distinction between adrenarche, precocious puberty and other
More informationISPUB.COM. F Iraji, A Momeni, S Naji, A Siadat BACKGROUND
ISPUB.COM The Internet Journal of Dermatology Volume 3 Number 2 The Efficacy Of Topical Cyproterone Acetate Alcohol Lotion Versus Placebo In The Treatment Of The Mild To Moderate Acne Vulgaris: A Double
More informationTopical Immunomodulator Step Therapy Program
Topical Immunomodulator Step Therapy Program Policy Number: 5.01.557 Last Review: 8/2017 Origination: 7/2013 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) BCBSKC will provide
More informationPapulonodular Dermatoses (Skin Disorders Characterized by the Presence of Bumps or Small Masses) Basics
Papulonodular Dermatoses (Skin Disorders Characterized by the Presence of Bumps or Small Masses) Basics OVERVIEW Papulonodular refers to the presence of papules and nodules; dermatosis (plural, dermatoses
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationAILMENTS. when you can have R E A C H US FACIAL EXPRESSIONS. Dr. Nivedita Dadu's Dermatology Clinic
R E A C H US Dr. Nivedita Dadu's Dermatology Clinic J-12/25, 1st Floor, Rajouri Garden, New Delhi - 110027, India www.drniveditadadu.com info@drniveditadadu.com +91 99585-73501 +91 98109-39319 WHY HAVE
More informationTazorac (tazarotene), Fabior (tazarotene), tazarotene powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.14.02 Subject: Tazarotene Page: 1 of 5 Last Review Date: June 12, 2014 Tazarotene Description Tazorac
More information